Inhibition of the CXCR4/PLC Signaling Increases Dexamethasone-Induced Sensitivity by Activating the Mitochondrial Apoptotic Pathway in B-Cell Acute Lymphoblastic Leukemia
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083489 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Souleymane Abdoul-Azize und 2 weiteren Autor:innen. Beteiligte Einrichtung: University Rouen Normandie, Inserm, UMR 1234, 76000 Rouen, France. Hauptthemen laut MEDLINE: Mitochondria, Dexamethasone, Receptors, CXCR4, Apoptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: La Ligue Contre le Cancer, Ligue Contre le Cancer, Comité Départemental de la Ligue Contre le Cancer, Comité de Loire-Atlantique.
Abstract (Originalsprache)
Understanding the mechanisms underlying glucocorticoid (GC) resistance in B-cell acute lymphoblastic leukemia (B-ALL) is essential to improve survival rates in relapsed children. We previously showed that GCs paradoxically induced their own resistance in B-ALL through CXCR4/PLC signaling, and that the inhibition of this pathway significantly reverses GC resistance in B-ALL cells and improves survival of GC-treated NSG mice in vivo. Here, we sought to determine whether the enhancement of GC sensitivity via inhibition of the CXCR4/PLC axis is associated with disruption of the mitochondrial pathway. Analysis of our previous transcriptomic data revealed that in B-ALL, the PLC inhibitor U73122 compromised multiple metabolic pathways related to metabolic reprogramming, mitochondrial function, and oxidative stress. Inhibition of PLC with U73122, protein kinase C with GF109203X, or CXCR4 with AMD3100 significantly potentiated dexamethasone (Dex)-induced mitochondrial membrane potential depolarization, reactive oxygen species production, cytochrome c release, caspase-3 activation, and decreased O2 consumption in B-ALL cells. These observations were also confirmed after Dex treatment in a B-ALL Nalm-6 cell line transfected with CXCR4 small interfering RNA. Moreover, co-treatment with Dex and CXCR4, PKC, or PLC inhibitors increased the levels of the pro-apoptotic protein BIM (BCL-2 interacting mediator of cell death) and, consequently, promoted the cell death process. Together, these findings suggest that the CXCR4/PLC axis reduces Dex efficacy by limiting mitochondrial apoptotic activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Rouen Normandie, Inserm, UMR 1234, 76000 Rouen, France.
- Department of Pediatric Immuno-Hemato-Oncology, University Hospital, 76000 Rouen, France.
Förderung
- La Ligue Contre le Cancer
- Ligue Contre le Cancer
- Comité Départemental de la Ligue Contre le Cancer, Comité de Loire-Atlantique
- Association “Vie et Espoir“
Zitieren
APA
Abdoul-Azize, S., Vannier, J. P., & Schneider, P. (2025). Inhibition of the CXCR4/PLC Signaling Increases Dexamethasone-Induced Sensitivity by Activating the Mitochondrial Apoptotic Pathway in B-Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083489
Vancouver
Abdoul-Azize S, Vannier JP, Schneider P. Inhibition of the CXCR4/PLC Signaling Increases Dexamethasone-Induced Sensitivity by Activating the Mitochondrial Apoptotic Pathway in B-Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083489
BibTeX
@article{AbdoulAzize2025,
author = {Abdoul-Azize, Souleymane and Vannier, Jean-Pierre and Schneider, Pascale},
title = {Inhibition of the CXCR4/PLC Signaling Increases Dexamethasone-Induced Sensitivity by Activating the Mitochondrial Apoptotic Pathway in B-Cell Acute Lymphoblastic Leukemia},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083489}
}
EUVIMED